Cosentyx 150MG/ML 2S
Ended Awarded Last action
- Contract number
- SPE2DR26FASWS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,293
Award facts
- Contract value 100% obligated
- $20,292.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,292.61 to AmerisourceBergen Drug Corp for the supply of COSENTYX 150MG/ML 2S, a pharmaceutical product. The contract was competitively awarded on December 18, 2025, with an ultimate completion date of December 19, 2025, and utilizes firm fixed-price pricing. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The company's extensive portfolio includes brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a critical vendor for the DLA Medical Supply Chain, AmerisourceBergen has demonstrated capability to meet federal procurement requirements through competitive procurement processes. The underlying SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply military healthcare programs worldwide, with the DLA Troop Support planning future Pharmaceutical Prime Vendor Global Program Generation V contracts that may involve multiple regional awards.
Quick answers
Who was awarded contract SPE2DR26FASWS?
SPE2DR26FASWS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FASWS worth?
The government has obligated $20,293 on SPE2DR26FASWS.
Is contract SPE2DR26FASWS an order under another contract?
Yes. SPE2DR26FASWS is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FASWS competed?
The extent of competition for SPE2DR26FASWS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award